Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Event Details

Filter
UKConference

23rd Annual Pharmaceutical Pricing and Market Access

Pharmaceutical Pricing & Market Access 2017 will tackle industry challenges head on by preparing attendees to develop a successful market access strategy for the ever changing pharmaceutical landscape

Add this event to your calendar: iCal   Google Calendar

Details

SMi Group presents the 23rd annual industry leading summit on Pharmaceutical Pricing & Market Access, 11 – 12 Oct 2017, London, UK.

Pharmaceutical Pricing & Market Access 2017 will tackle industry challenges head on by preparing attendees to develop a successful market access strategy for the ever changing pharmaceutical and payer landscape. Join us this autumn for insight into how manufactures plan to limit further price increase; a progressive outlook into the future of pharmaceutical pricing & reimbursement (P&R); and discuss what can be done for the industry to achieve efficient reimbursement and for patients to gain access to affordable medication.

Featured Speakers:

Barbara Jaszewski, VP Global Pricing & Market Access, Lundbeck
Nneka Onwudiwe, PRO/PE Regulatory Review Officer, FDA
Patrick Mollon, Dir Health-Economics, Outcomes Research & Epidemiology, Shire
Fabrizio Zucca, Dir Patient Access, Sobi
Klaas Postema, Sr Dir Market Access & Pricing Generics Europe, Teva
Mercedes Prior, International Market Access Dir, Grifols
Anne Marciniak, Sr Dir, International HEOR, Allergan
Ritva Lehtonen, Market Access & External Affairs Dir, Sanofi

Reasons to Join:

Increase compliance through regulatory guidance by the FDA
Develop strategies for market access and expansion by identifying key economic advantages and by optimising meaningful patient engagement
Generate clinical and health economic evidence to support a strong value proposition
Utilise strategic partnerships by collaborating with payers, data providers and health stakeholders
Uncover new windows of opportunity in growing markets such as orphan drugs, biosimilars and gene therapy
Discover how the HTA and Regulatory Agencies are working together to meet patient needs
Hear updates on translational market access, international reference pricing and value based pricing
Implement real world data into pricing and utilise Real World Evidence (RWE) for payer decision making

Prices

Conference + Two Workshops: GBP 2697 Conference + One Workshop: GBP 2098 Conference Only: GBP 1499

Contact

Teri Arri
tarri@smi-online.co.uk

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.